 GE HealthCare Technologies shares rose on Wednesday after the company issued preliminary results for the fourth quarter and forecast continued organic revenue growth in the year ahead. The company, which completed its spin-off from General Electric NYSE:GE last week, said it expects 2023 organic revenue to grow by 5 to 7 from 2022 levels. 